AI-generated summary
In this randomized trial of 48 head and neck cancer patients receiving radiotherapy, the authors compared photobiomodulation plus oral care with oral care alone. They report that photobiomodulation was effective in preventing and treating severe oral mucositis and that the control group had higher oral health-related quality of life impacts, mainly at the final stage of treatment. The authors also report that the PROMS scale was helpful for assessing mucositis severity.
- Participants
- 48
- Who or what was studied
- Patients with head and neck cancer undergoing radiotherapy
- Limits stated in the abstract
- The abstract does not state the wavelengths used or describe the treatment parameters in detail.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Control group, Oral mucositis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.